Cargando…

The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications

Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-prot...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemminki, Kari, Försti, Asta, Tuuminen, Raimo, Hemminki, Otto, Goldschmidt, Hartmut, Sundquist, Kristina, Sundquist, Jan, Li, Xinjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916420/
https://www.ncbi.nlm.nih.gov/pubmed/27328652
http://dx.doi.org/10.1038/srep28500
_version_ 1782438826725081088
author Hemminki, Kari
Försti, Asta
Tuuminen, Raimo
Hemminki, Otto
Goldschmidt, Hartmut
Sundquist, Kristina
Sundquist, Jan
Li, Xinjun
author_facet Hemminki, Kari
Försti, Asta
Tuuminen, Raimo
Hemminki, Otto
Goldschmidt, Hartmut
Sundquist, Kristina
Sundquist, Jan
Li, Xinjun
author_sort Hemminki, Kari
collection PubMed
description Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-protein. We noted that MGUS diagnosis often coincided with diagnoses of senile cataract and glaucoma and tested the associations of MGUS, MM, WM and AL amyloidosis with subsequent eye diseases identified from the Swedish patient registers between 1997 and 2012. Standardized incidence ratios (SIRs) for senile cataract was significantly increased to 1.80 after MGUS, 1.70 after MM, 1.85 after WM and 2.31 after AL amyloidosis. The SIR for glaucoma was 1.60 after MGUS, 1.76 after WM and 2.18 after AL amyloidosis. All SIRs decreased systematically from age below 60 years to over 79 years, but most risks were also significant in age group over 79 years. The M-protein and the related increase in blood viscosity could be a novel etiologic discovery for these common eye diseases. As MGUS prevalence is around 3% at 60 years and close to 10% at age over 80 years, its contribution to the eye disease burden is expected to be remarkably high.
format Online
Article
Text
id pubmed-4916420
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-49164202016-06-27 The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications Hemminki, Kari Försti, Asta Tuuminen, Raimo Hemminki, Otto Goldschmidt, Hartmut Sundquist, Kristina Sundquist, Jan Li, Xinjun Sci Rep Article Plasma cell dyscrasias, including monoclonal gammopathy of undetermined significance (MGUS), multiple myeloma (MM), Waldenström macroglobulinemia (WM) and light chain AL amyloidosis, are characterized by clonal expansion of plasma cells which produce a vast amount of an immunoglobulin-derived M-protein. We noted that MGUS diagnosis often coincided with diagnoses of senile cataract and glaucoma and tested the associations of MGUS, MM, WM and AL amyloidosis with subsequent eye diseases identified from the Swedish patient registers between 1997 and 2012. Standardized incidence ratios (SIRs) for senile cataract was significantly increased to 1.80 after MGUS, 1.70 after MM, 1.85 after WM and 2.31 after AL amyloidosis. The SIR for glaucoma was 1.60 after MGUS, 1.76 after WM and 2.18 after AL amyloidosis. All SIRs decreased systematically from age below 60 years to over 79 years, but most risks were also significant in age group over 79 years. The M-protein and the related increase in blood viscosity could be a novel etiologic discovery for these common eye diseases. As MGUS prevalence is around 3% at 60 years and close to 10% at age over 80 years, its contribution to the eye disease burden is expected to be remarkably high. Nature Publishing Group 2016-06-22 /pmc/articles/PMC4916420/ /pubmed/27328652 http://dx.doi.org/10.1038/srep28500 Text en Copyright © 2016, Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Article
Hemminki, Kari
Försti, Asta
Tuuminen, Raimo
Hemminki, Otto
Goldschmidt, Hartmut
Sundquist, Kristina
Sundquist, Jan
Li, Xinjun
The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
title The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
title_full The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
title_fullStr The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
title_full_unstemmed The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
title_short The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications
title_sort incidence of senile cataract and glaucoma is increased in patients with plasma cell dyscrasias: etiologic implications
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916420/
https://www.ncbi.nlm.nih.gov/pubmed/27328652
http://dx.doi.org/10.1038/srep28500
work_keys_str_mv AT hemminkikari theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT forstiasta theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT tuuminenraimo theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT hemminkiotto theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT goldschmidthartmut theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT sundquistkristina theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT sundquistjan theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT lixinjun theincidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT hemminkikari incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT forstiasta incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT tuuminenraimo incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT hemminkiotto incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT goldschmidthartmut incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT sundquistkristina incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT sundquistjan incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications
AT lixinjun incidenceofsenilecataractandglaucomaisincreasedinpatientswithplasmacelldyscrasiasetiologicimplications